Shil Patel
Vice President
Codiak Biosciences
Cambridge, MA, USA
More than 25 years of experience in the pharmaceutical industry spanning roles to include developing primary and functional in-vitro, ex-vivo and in-vivo screens for CNS therapeutics through to non-invasive imaging modalities, including small molecule, monoclonal antibody and ASO based nuclear imaging (PET and SPECT) in rodents and non-human primates. Have led and collaborated with multidisciplinary teams utilizing, multi-modality imaging approaches to de-risk and drive therapeutic programs across several therapeutic areas including neurology, neuroimmunology, oncology and hemophilia. Current role involves utilizing discovery and translational approaches to help drive Codiak’s exosome platform through the clinic.
Scientific Expertise
PET/SPECT, Neuroscience
Mentoring Interests
Scientific Writing, Networking, Leadership Skills
In my free time, I enjoy…
Most sports, traveling